)
)
Q32 Bio Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Q32 Bio Inc
Access all reports
Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing biologic therapeutics designed to restore immune balance in patients with autoimmune and inflammatory diseases. The company's product pipeline includes innovative treatments targeting both the innate and adaptive immune systems. The company is based in Waltham, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Q32 Bio Inc
Q3 2024
Q32 Bio Inc
Corporate Presentation
Q32 Bio Inc
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
QTTB
Country
🇺🇸 United States